The interaction between p53 and MDM2 represents a key therapeutic target in several cancers where MDM2 overexpression suppresses p53 activity. Despite extensive research, the discovery of potent and ...
In the era of targeted therapies, molecules for the reactivation of the oncosuppressor p53 in human cancer have not yet reached FDA or EMA approval. Recently, the interaction region of the MDM2/MDM4 ...
The Environmental Source Apportionment Toolkit (ESAT) is an open-source software package that provides API and CLI functionality to create source apportionment workflows specifically targeting ...
G protein-coupled receptors (GPCRs) and G proteins work together to transmit signals from various hormone and neurotransmitter molecules across cell membranes, and their activation and subsequent ...
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer In total, 346 sequencing reports were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results